Local Institution

Xi'an, Shan3xi 710061

0 studies enrolling now · 5 studies all time

What they study most

Chronic Hepatitis B, Hepatocellular Carcinoma, Lupus Nephritis, Non-Small-Cell Lung Carcinoma, Various Advanced Cancer

Studies at this site

• An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer — Completed
• A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy — Completed
• An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis — Stopped early
• Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC — Completed
• Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed